Calliditas Therapeutics AB
(NASDAQ:CALT)
$17.90
0.285[1.62%]
Last update: 8:44AM (Delayed 15-Minutes)
Get Real Time Here
$17.90
0[0.00%]
Open18.000Close18.260
Vol / Avg.10.169K / 9.183KMkt Cap480.365M
Day Range17.560 - 18.26052 Wk Range10.820 - 25.640

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Calliditas Therapeutics Stock (NASDAQ:CALT) Earnings Dates and Earning Calls

Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 13

EPS Estimate

$-0.310

Quarterly Revenue Estimate

$28.3M

Annual Revenue (as of Jun 30)

$1.1B

Earnings History

Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A

Calliditas Therapeutics (CALT) is scheduled to report earnings on November 13, 2023. The last reported earnings were for reported on August 17, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Calliditas Therapeutics (NASDAQ:CALT)?

A

The Actual EPS was $-0.32, which missed the estimate of $-0.18.

Q

What were Calliditas Therapeutics’s (NASDAQ:CALT) revenues?

A

The Actual Revenue was $25.6M, which missed the estimate of $28.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved